Stay updated on Lebrikizumab Efficacy in Japanese & Caucasian Volunteers Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Efficacy in Japanese & Caucasian Volunteers Clinical Trial page.

Latest updates to the Lebrikizumab Efficacy in Japanese & Caucasian Volunteers Clinical Trial page
- Check2 days agoChange DetectedA notice was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer’s revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows Revision: v3.7.0, and a large portion of legacy study-content blocks (investigators, sponsor, record dates, eligibility criteria, locations, and related descriptions) were removed or reorganized, indicating a restructuring of the study record presentation.SummaryDifference15%

- Check58 days agoChange DetectedThe page version updated from v3.6.5 to v3.6.6, signaling a maintenance or UI update. This change appears to affect only the interface, with no modification to study data or eligibility details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe site version has been updated from v3.6.4 to v3.6.5, signaling a maintenance release that is likely to include minor fixes or improvements without altering the displayed study information.SummaryDifference0.1%

Stay in the know with updates to Lebrikizumab Efficacy in Japanese & Caucasian Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Efficacy in Japanese & Caucasian Volunteers Clinical Trial page.